Cargando…
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
Autores principales: | O'Brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-Schwarz, V A, Murali, R, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, DeFazio, A, Quinn, Di, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410105/ http://dx.doi.org/10.1038/sj.bjc.6604419 |
Ejemplares similares
-
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
por: O'Brien, P M, et al.
Publicado: (2008) -
A distinct molecular profile associated with mucinous epithelial ovarian cancer
por: Heinzelmann-Schwarz, V A, et al.
Publicado: (2006) -
MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
por: Byrne, Jennifer A, et al.
Publicado: (2010) -
The EDD E3 ubiquitin ligase ubiquitinates and up-regulates β-catenin
por: Hay-Koren, Avital, et al.
Publicado: (2011) -
Évaluation pronostique de la COVID-19 : score GAP versus indice EDD
por: Khaldi, S., et al.
Publicado: (2023)